Salomon & Ludwin’s Repligen RGEN Stock Holding History

Salomon & Ludwin’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10	Closed	-$1.18K	–	2160
2026 Q1	$1.18K	Hold	10	–	–	﹤0.01%	1993
2025 Q4	$1.69K	Hold	10	–	–	﹤0.01%	2017
2025 Q3	$1.49K	Buy	+10	New	+$1.22K	﹤0.01%	2014

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Salomon & Ludwin's RGEN Position: Q2 2026 in Review

Salomon & Ludwin sold out of Repligen (RGEN) in Q2 2026, closing a stake of 10 shares — an estimated $1.18K sold.

Salomon & Ludwin first reported a position in RGEN in Q3 2025 and held it in 3 quarters. The position peaked at $1.69K in Q4 2025. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Salomon & Ludwin reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
Salomon & Ludwin sold 10 Repligen shares in Q2 2026, an estimated $1.18K.
Salomon & Ludwin first reported a position in Repligen in Q3 2025 and held it in 3 quarters.
Salomon & Ludwin's Repligen position peaked at $1.69K in Q4 2025.
477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.